Allergan Plc (AGN)

166.08
NYSE : Health Technology
Prev Close 165.85
Day Low/High 165.16 / 167.21
52 Wk Low/High 114.27 / 197.00
Avg Volume 3.84M
Exchange NYSE
Shares Outstanding 327.82M
Market Cap 54.37B
EPS -15.30
P/E Ratio N/A
Div & Yield 2.96 (1.76%)
Allergan Receives FDA Clearance For CoolTone™ Device

Allergan Receives FDA Clearance For CoolTone™ Device

MAGNETIC MUSCLE STIMULATION TECHNOLOGY TO STRENGTHEN, TONE AND FIRM MUSCLES

Wild Week Ahead

The intermediate-term sentiment indicators don’t show too much giddiness -- yet -- but look at all the market has on its plate this week.

FDA Approves BOTOX® (onabotulinumtoxinA) For Pediatric Patients With Upper Limb Spasticity

FDA Approves BOTOX® (onabotulinumtoxinA) For Pediatric Patients With Upper Limb Spasticity

--BOTOX® is the First Neurotoxin Treatment Approved to Treat Pediatric Patients, 2 to 17 Years of Age, with Upper Limb Spasticity--

Aegon Announces Purchase Of Shares To Neutralize 2018 Final Stock Dividend

Aegon Announces Purchase Of Shares To Neutralize 2018 Final Stock Dividend

Aegon will repurchase 32,873,805 common shares to neutralize the dilutive effect of the 2018 final stock dividend.

Ironwood And Allergan Report Positive Topline Data From Phase IIIb Trial Of LINZESS® (linaclotide) In Adults With Irritable Bowel Syndrome With Constipation (IBS-C)

Ironwood And Allergan Report Positive Topline Data From Phase IIIb Trial Of LINZESS® (linaclotide) In Adults With Irritable Bowel Syndrome With Constipation (IBS-C)

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) and  Allergan plc (NYSE:AGN) today announced positive topline data from a Phase IIIb clinical trial evaluating LINZESS (linaclotide) 290 mcg on multiple abdominal symptoms in adult patients with IBS-C.

Aegon Bank Successfully Prices Inaugural EUR 500 Million Senior Non-Preferred Notes

Aegon Bank Successfully Prices Inaugural EUR 500 Million Senior Non-Preferred Notes

Today, Aegon Bank priced its inaugural EUR 500 million 5 year Senior Non-Preferred notes with a yield of 0.

FDA Approves Amgen And Allergan's KANJINTI™ (trastuzumab-anns), A Biosimilar To Herceptin® (trastuzumab)

FDA Approves Amgen And Allergan's KANJINTI™ (trastuzumab-anns), A Biosimilar To Herceptin® (trastuzumab)

Approval Based on Totality of Evidence Demonstrating KANJINTI is Biosimilar to Herceptin

Moderna, Six Flags, Chevron and More: 'Mad Money' Lightning Round

Moderna, Six Flags, Chevron and More: 'Mad Money' Lightning Round

A roundup of Jim Cramer's thoughts on stocks of interest to Mad Money viewers.

We're in Bizarro Land: Cramer's 'Mad Money' Recap (Wednesday 6/5/19)

We're in Bizarro Land: Cramer's 'Mad Money' Recap (Wednesday 6/5/19)

Investors should consider recession-proof names in the current environment, Jim Cramer says.

Watch These 9 Companies in a Botox Export Boom Out of South Korea

Watch These 9 Companies in a Botox Export Boom Out of South Korea

South Korea is the plastic surgery capital of the world. These companies are manufacturing botox strains - but the big business is abroad, if they can crack the China and U.S. markets.

Bas NieuweWeme Appointed As CEO Of Aegon Asset Management

Bas NieuweWeme Appointed As CEO Of Aegon Asset Management

Aegon today announces that Sarah Russell (1962, Australian), member of Aegon's Management Board and Global CEO of Aegon Asset Management, will step down.

Allergan And Gedeon Richter Receive U.S. FDA Approval For Expanded Use Of VRAYLAR® (cariprazine) In The Treatment Of Bipolar Depression

Allergan And Gedeon Richter Receive U.S. FDA Approval For Expanded Use Of VRAYLAR® (cariprazine) In The Treatment Of Bipolar Depression

- New Indication Makes VRAYLAR First and Only Dopamine and Serotonin Partial Agonist to Treat the Full Spectrum of Bipolar I Symptoms in Manic, Mixed, and Depressive Episodes -

Allergan Announces Updated Presentation Time At The Bernstein Strategic Decisions Conference

Allergan Announces Updated Presentation Time At The Bernstein Strategic Decisions Conference

DUBLIN, May 24, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that Chairman and CEO Brent Saunders will participate in a fireside chat at the Bernstein 35 th Annual Strategic Decisions Conference in New York, NY.

Allergan To Present At The Jefferies 2019 Healthcare Conference

Allergan To Present At The Jefferies 2019 Healthcare Conference

DUBLIN, May 23, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that Chief Commercial Officer William Meury will participate in a fireside chat at the Jefferies 2019 Healthcare Conference in New York, NY.

Allergan Expands PLEDGE Clinical Research Program In Diabetic Gastroparesis

Allergan Expands PLEDGE Clinical Research Program In Diabetic Gastroparesis

-- Five PLEDGE studies now active and enrolling patients to evaluate the safety and efficacy of relamorelin (investigational drug) in people with diabetic gastroparesis --

Aegon To Divest Stake In Partnership With Sony Life In Japan

Aegon To Divest Stake In Partnership With Sony Life In Japan

"With the evolving market conditions, we mutually agreed that the future of the variable annuity business in Japan is best served as a wholly-owned part of our longstanding partner Sony Life", said Alex Wynaendts, CEO of Aegon.

China Winners and Losers: Cramer's 'Mad Money' Recap (Thursday 5/16/19)

China Winners and Losers: Cramer's 'Mad Money' Recap (Thursday 5/16/19)

Jim Cramer says Thursday's market action showed us a rally based on good old-fashioned earnings.

Jim Cramer: These 7 True Laggards Have Caught Fire

Jim Cramer: These 7 True Laggards Have Caught Fire

These kinds of stocks are what goes up when there's so little left that hasn't moved that can still be worth buying.

Allergan To Present At The Bernstein Strategic Decisions Conference

Allergan To Present At The Bernstein Strategic Decisions Conference

DUBLIN, May 16, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that Chairman and CEO Brent Saunders will participate in a fireside chat at the Bernstein 35 th Annual Strategic Decisions Conference in New York, NY.

Allergan To Present VRAYLAR® (cariprazine) Data At The American Psychiatric Association (APA) 2019 Annual Meeting Highlighting Continued Commitment To Mental Health

Allergan To Present VRAYLAR® (cariprazine) Data At The American Psychiatric Association (APA) 2019 Annual Meeting Highlighting Continued Commitment To Mental Health

Abstracts will showcase research on VRAYLAR, including a focus on an investigational use for the treatment of bipolar depression

PatientFi® Announces Study Partnership With Allergan

PatientFi® Announces Study Partnership With Allergan

PatientFi, LLC, a leading financial technology company that partners with medical practices to offer patients accessible financing plans for elective procedures, is pleased to announce its partnership with Allergan plc on a year-long market research study...

Novartis to Buy Takeda's Eye Drug in $5.3 Billion Deal

Novartis to Buy Takeda's Eye Drug in $5.3 Billion Deal

Novartis gets a potentially blockbuster eye drug and Takeda gets to unload some debt and employees it took on when it purchased Shire.

Allergan To Present At The Bank Of America Merrill Lynch 2019 Health Care Conference

Allergan To Present At The Bank Of America Merrill Lynch 2019 Health Care Conference

DUBLIN, May 9, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that Chief Financial Officer Matthew Walsh will participate in a fireside chat at the Bank of America Merrill Lynch 2019 Health Care Conference in Las Vegas, Nevada.

Dow Falls Nearly 500 Points as U.S.-China Trade Talk Fears Return

Dow Falls Nearly 500 Points as U.S.-China Trade Talk Fears Return

Stocks end down sharply as markets react to latest twists in trade spat between the U.S. and China.

Regeneron Stock Could Fall 13% to 52-Week Lows

Regeneron Stock Could Fall 13% to 52-Week Lows

Regeneron stock is under pressure after missing on earnings and revenue expectations. Are new lows on tap?

Allergan Tops Q1 Earnings Estimate, Boosts Full-Year Profit Outlook

Allergan Tops Q1 Earnings Estimate, Boosts Full-Year Profit Outlook

Allergan posted stronger-than-expected first quarter earnings Tuesday, and boosted its full-year profit guidance, as Botox sales continue to drive top-line growth for the Dublin-based pharmaceutical group.

Allergan Stock Slips Despite Beat and Raised Guidance

Allergan Stock Slips Despite Beat and Raised Guidance

Shares of the maker of Botox are struggling despite its latest results exceeding expectations.

Global Stocks Drift As China Confirms Trade Participation, US Warns on Tariffs

Global Stocks Drift As China Confirms Trade Participation, US Warns on Tariffs

Global stocks were mixed higher Tuesday, while U.S. equity futures drifted modestly into the red, as investors kept risk appetite in check ahead of a key series of trade talks between Washington and Beijing later this week that could define or collapse an elusive pact between the world's two largest economies.

Lyft, Anadarko, AIG, AB InBev and Trade Talks - 5 Things You Must Know

Lyft, Anadarko, AIG, AB InBev and Trade Talks - 5 Things You Must Know

U.S. stock futures slump as investors focus on trade talks later this week between Washington and Beijing; Lyft will issue its first earnings report as a public company on Tuesday; Anadarko says it favors Occidental's takeover bid over Chevron's offer.

TheStreet Quant Rating: C (Hold)